DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. $(GILD)$ rallied 1.85% to $95.59 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.47% to 6,039.31 and Dow Jones Industrial Average falling 0.31% to 44,713.52.
Gilead Sciences Inc. closed 3.35% below its 52-week high of $98.90, which the company achieved on November 11th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 0.51% to $151.15, Pfizer Inc. $(PFE)$ fell 0.49% to $26.62, and Abbott Laboratories $(ABT)$ rose 0.37% to $127.86.
Trading volume (5.6 M) remained 1.3 million below its 50-day average volume of 6.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 29, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 29, 2025 16:39 ET (21:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。